USD 9.5 Billion
Pneumonia Therapeutics Market Size, Share, Growth Analysis, By Treatment(Antibiotics, antiviral drugs, and supportive care), By Distribution channel(Hospital pharmacies, retail pharmacies, and online platforms), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35A2498 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
63
|Figures:
75
Pneumonia Therapeutics Market Insights
Global Pneumonia Therapeutics Market size was valued at USD 9.5 Billion in 2022 and is poised to grow from USD 10.36 Billion in 2023 to USD 20.63 Billion by 2031, at a CAGR of 9% during the forecast period (2024-2031).
The global pneumonia therapeutics market is driven by factors such as the rising prevalence of pneumonia, especially among the elderly and immunocompromised individuals, and the increasing development of innovative treatment options.
Community-acquired pneumonia, which is acquired outside of healthcare facilities, remained a significant concern. There was an increasing awareness of the importance of early diagnosis and appropriate treatment of CAP.
This trend led to improved diagnostic techniques, more accurate assessment tools, and guidelines for healthcare practitioners to optimize treatment outcomes.
The market is characterized by a range of antibiotics, antiviral drugs, and supportive care therapies.
With advancements in medical technology and a growing focus on personalized medicine, the market is witnessing research and development efforts aimed at more targeted and efficient treatments.
However, challenges include antibiotic resistance and access to healthcare in certain regions.
Overall, the pneumonia therapeutics market is poised for growth due to ongoing medical advancements and demographic trends.
US Pneumonia Therapeutics Market is poised to grow at a sustainable CAGR for the next forecast year.
Market Snapshot - 2024-2031
Global Market Size
Largest Segment
Hospital pharmacies
Fastest Growth
Hospital pharmacies
Growth Rate
9% CAGR
Global Pneumonia Therapeutics Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Pneumonia Therapeutics Market Segmental Analysis
The global pneumonia therapeutics market can be segmented based on treatment, distribution channel, and region. Treatment types include antibiotics, antiviral drugs, and supportive care. Distribution channels involve hospital pharmacies, retail pharmacies, and online platforms. Geographically, the market is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Pneumonia Therapeutics Market Analysis By Treatment
The largest segment in the pneumonia therapeutics market is likely the antibiotics segment, given the prevalence of bacterial pneumonia cases. Antibiotics have been the mainstay of treatment for bacterial pneumonia, and they continue to be prescribed widely.
The fastest-growing segment could vary based on factors such as emerging infectious agents, changes in pneumonia epidemiology, and advancements in treatment options. For example, with the development of antiviral drugs and vaccines, the antiviral segment has seen significant growth, especially in cases where viral pneumonia was prominent due to outbreaks like COVID-19.
Pneumonia Therapeutics Market Analysis By Distribution Channel
The largest and fastest-growing distribution channels can vary based on regional factors, healthcare infrastructure, and patient preferences. In many regions, hospitals tend to be the largest distribution channel due to the severity of pneumonia cases that require hospitalization. The fastest-growing channel could be online pharmacies due to the increasing adoption of online shopping and the convenience it offers.
Additionally, with advancements in telemedicine, more patients might be receiving prescriptions through virtual consultations, which could impact the distribution landscape. This could particularly be the case for mild to moderate cases of pneumonia where patients don't need to physically visit a healthcare facility.
Global Pneumonia Therapeutics Market By Distribution channel
To get detailed analysis on other segments, Request For Free Sample Report
Pneumonia Therapeutics Market Regional Insights
North America, including the United States and Canada, traditionally has a strong healthcare infrastructure and access to advanced medical treatments. The presence of major pharmaceutical companies and research institutions contributes to the growth of the pneumonia therapeutics market in this region.
European countries, with their well-established healthcare systems and increasing awareness about respiratory diseases, contribute significantly to the pneumonia therapeutics market. Countries like the United Kingdom, Germany, France, and Italy are prominent players in this market. Asia-Pacific has been witnessing rapid growth in the healthcare sector, driven by increasing healthcare expenditure, rising awareness, and a large patient population. Countries like China, India, and Japan are major contributors to the pneumonia therapeutics market's growth in this region.
Global Pneumonia Therapeutics Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Pneumonia Therapeutics Market Dynamics
Pneumonia Therapeutics Market Drivers
Increasing Incidence of Pneumonia
- Pneumonia is a significant global health concern, particularly in vulnerable populations such as the elderly, young children, and individuals with compromised immune systems. The rising incidence of pneumonia drives the demand for effective therapeutics to treat the condition.
Advancements in Research and Development
- Ongoing research and development efforts have led to the discovery of new treatment options and innovative approaches for pneumonia. These advancements can enhance the effectiveness of existing treatments or introduce novel therapies, expanding the market and providing better treatment outcomes for patients.
Pneumonia Therapeutics Market Restraints
Antibiotic Resistance
- Antibiotic resistance is a major concern in pneumonia treatment. Overuse and misuse of antibiotics have contributed to the emergence of drug-resistant bacterial strains, making certain treatments less effective. This limits the available options for treating pneumonia and creates a need for alternative therapies.
High Treatment Costs
- Developing and manufacturing new pneumonia therapeutics can be costly, and these expenses can be passed on to patients and healthcare systems. High treatment costs might limit access to effective treatments, especially in regions with limited healthcare resources or lack of insurance coverage.
Request Free Customization of this report to help us to meet your business objectives.
Pneumonia Therapeutics Market Competitive Landscape
The global pneumonia therapeutics market showcases intense competition among pharmaceutical companies, including industry giants and emerging players. Established firms leverage their R&D expertise and extensive distribution networks to maintain dominance, while newer entrants focus on innovative treatments and personalized approaches. Key strategies encompass drug development, clinical trials, partnerships for novel therapies, and geographic expansion. Market dynamics are shaped by factors such as government regulations, reimbursement policies, and advancements in precision medicine. With a strong emphasis on research, collaboration, and technological advancements, the market strives to enhance treatment outcomes, reduce mortality rates, and address the evolving challenges posed by pneumonia.
Pneumonia Therapeutics Market Top Player’s Company Profiles
- Pfizer Inc. - USA
- GlaxoSmithKline plc (GSK) - UK
- AstraZeneca plc - UK
- Novartis AG - Switzerland
- Roche Holding AG - Switzerland
- Merck & Co., Inc. - USA
- Sanofi - France
- Johnson & Johnson - USA
- Eli Lilly and Company - USA
- Bayer AG - Germany
- Boehringer Ingelheim - Germany
- AbbVie Inc. - USA
- Bristol Myers Squibb - USA
- Teva Pharmaceutical Industries Ltd. - Israel
- Mylan N.V. - USA
- Allergan (now part of AbbVie) - USA
- Vertex Pharmaceuticals - USA
- Astellas Pharma Inc. - Japan
- Daiichi Sankyo Co., Ltd. - Japan
- Takeda Pharmaceutical Company Limited - Japan
Pneumonia Therapeutics Market Recent Developments
- In January 2023, Pfizer Inc. acquired ReViral Ltd., a clinical-stage biopharmaceutical company developing novel antivirals for respiratory diseases.
- In February 2023, AstraZeneca plc acquired TeneoTwo Inc., a clinical-stage biopharmaceutical company developing novel antibiotics for the treatment of pneumonia and other serious infections.
- In March 2023, Johnson & Johnson acquired Zydus Lifesciences Ltd.'s pneumonia vaccine business.
Pneumonia Therapeutics Key Market Trends
- Rise in Drug Development and Research: There was a growing emphasis on research and development in the field of pneumonia therapeutics. With the emergence of drug-resistant strains of bacteria and a need for more effective treatments, pharmaceutical companies were investing in the development of novel antibiotics and other therapeutic approaches to combat pneumonia. This trend was particularly important due to concerns about the potential for antibiotic-resistant infections.
- Focus on Vaccination and Prevention: Pneumonia is a preventable disease, and there was a strong focus on vaccination efforts, especially for high-risk populations such as the elderly, young children, and individuals with compromised immune systems. Vaccines like the pneumococcal conjugate vaccine (PCV) and the influenza vaccine were being promoted to reduce the incidence of pneumonia and its complications.
Pneumonia Therapeutics Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Product types team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analysis, the global pneumonia therapeutics market is anticipated to witness sustained growth due to factors such as rising awareness, advancements in treatment options, and a growing elderly population susceptible to respiratory infections. Innovations in drug development and targeted therapies, coupled with ongoing research into pneumonia's diverse causes, are expected to drive market expansion. Additionally, the integration of telemedicine and personalized medicine approaches could further enhance treatment outcomes. However, challenges such as antibiotic resistance and access to healthcare in certain regions might influence market dynamics. Overall, the pneumonia therapeutics market is poised for development as science and technology continue to advance.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 9.5 Billion |
| Market size value in 2031 | USD 20.63 Billion |
| Growth Rate | 9% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Pneumonia Therapeutics Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Pneumonia Therapeutics Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Pneumonia Therapeutics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Pneumonia Therapeutics Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Pneumonia Therapeutics Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Pneumonia Therapeutics Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
